Optimal management of familial hypercholesterolemia: treatment and management strategies

被引:26
作者
Nemati, Mohammad Hassan [1 ]
Astaneh, Behrooz [2 ]
机构
[1] Faghihi Hosp, Cardiac Surg Dept, Shiraz, Iran
[2] Shiraz Univ Med Sci, Vice Chancellor Res Dept, Zand St, Shiraz, Iran
关键词
familial hypercholesterolemia; homozygote; heterozygote; Iran;
D O I
10.2147/VHRM.S8283
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Familial hypercholesterolemia is an autosomally dominant disorder caused by various mutations in low-density lipoprotein receptor genes. This will lead to elevated levels of total and low-density lipoprotein cholesterol, which may in turn lead to premature coronary atherosclerosis and cardiac-related death. The symptoms are more severe in the homozygous type of the disease. Different options for the treatment of affected patients are now available. Diet therapy, pharmacologic therapy, lipid apheresis, and liver transplantation are among the various treatments. We clinically review the treatment and management strategies for the disease in order to shed light on the optimal management of familial hypercholesterolemia.
引用
收藏
页码:1079 / 1088
页数:10
相关论文
共 77 条
[1]  
Aggoun Y, 2000, ARTERIOSCL THROM VAS, V20, P2070
[2]   Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia [J].
Akdim, Fatima ;
Visser, Maartje E. ;
Tribble, Diane L. ;
Baker, Brenda F. ;
Stroes, Erik S. G. ;
Yu, Rosie ;
Flaim, Joann D. ;
Su, John ;
Stein, Evan A. ;
Kastelein, John J. P. .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (10) :1413-1419
[3]   Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: Report of the first case and review of the literature [J].
Alkofer, BJ ;
Chiche, L ;
Khayat, A ;
Deshayes, JP ;
Lepage, A ;
Saloux, E ;
Reznik, Y .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (05) :2250-2252
[4]  
Alonso Rodrigo, 2005, Expert Opin Drug Saf, V4, P171, DOI 10.1517/14740338.4.2.171
[5]   Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-analysis [J].
Arambepola, C. ;
Farmer, A. J. ;
Perera, R. ;
Neil, H. A. W. .
ATHEROSCLEROSIS, 2007, 195 (02) :339-347
[6]   Familial hypercholesterolemia and coronary heart disease: A HuGE association review [J].
Austin, MA ;
Hutter, CM ;
Zimmern, RL ;
Humphries, SE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (05) :421-429
[7]  
Avellone G, 2006, INT ANGIOL, V25, P26
[8]   A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia [J].
Avis, H. J. ;
Vissers, M. N. ;
Stein, E. A. ;
Wijburg, F. A. ;
Trip, M. D. ;
Kastelein, J. J. P. ;
Hutten, B. A. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (08) :1803-1810
[9]   Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia [J].
Avis, Hans J. ;
Hutten, Barbara A. ;
Gagne, Claude ;
Langslet, Gisle ;
McCrindle, Brian W. ;
Wiegman, Albert ;
Hsia, Judith ;
Kastelein, John J. P. ;
Stein, Evan A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (11) :1121-1126
[10]   Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia - A prospective, randomized, double-blind trial [J].
Ballantyne, CM ;
Houri, J ;
Notarbartolo, A ;
Melani, L ;
Lipka, LJ ;
Suresh, R ;
Sun, S ;
LeBeaut, AP ;
Sager, PT ;
Veltri, EP .
CIRCULATION, 2003, 107 (19) :2409-2415